Back
Black Diamond Therapeutics Vs. Ligand Pharmaceuticals Industry Stock Comparison
Sell
34
BDTX
Black Diamond Therapeutics
Last Price:
3.26
Seasonality Move:
8.38%
Buy
59
LGND
Ligand Pharmaceuticals
Last Price:
111.11
Seasonality Move:
12.9%
Sell
34
Black Diamond Therapeutics (BDTX)
is a Sell
Is Black Diamond Therapeutics a Buy, Sell or Hold?
- The current Black Diamond Therapeutics [BDTX] share price is $2.99. The Score for BDTX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- BDTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Ligand Pharmaceuticals (LGND)
is a Buy
Is Ligand Pharmaceuticals a Buy, Sell or Hold?
- The current Ligand Pharmaceuticals [LGND] share price is $110.15. The Score for LGND is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- LGND is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BDTX Stock Price Chart
What is Black Diamond Therapeutics's stock price today?
-
The Black Diamond Therapeutics share price today is $2.99
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDTX is experiencing slight selling pressure.
LGND Stock Price Chart
What is Ligand Pharmaceuticals's stock price today?
-
The Ligand Pharmaceuticals share price today is $110.15
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LGND is experiencing buying pressure, which is a positive indicator for future bullish movement.
BDTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.41 | Sell |
| Relative Strength Index (14 RSI): | 35.32 | Sell |
| Chaikin Money Flow: | -24371 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.95 - 3.77) | Sell |
| Bollinger Bands (100): | (3.81 - 5.99) | Sell |
LGND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.1 | Buy |
| Relative Strength Index (14 RSI): | 56.31 | Buy |
| Chaikin Money Flow: | 52376 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (101.79 - 110.19) | Buy |
| Bollinger Bands (100): | (90.57 - 108.59) | Buy |
BDTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.91 | Buy |
| 20-day SMA: | 3.2 | Sell |
| 50-day SMA: | 4.41 | Sell |
| 200-day SMA: | 4.89 | Sell |
| 8-day EMA: | 2.96 | Buy |
| 20-day EMA: | 3.27 | Sell |
| 50-day EMA: | 4.01 | Sell |
| 200-day EMA: | 4.5 | Sell |
LGND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 110.93 | Sell |
| 20-day SMA: | 107.05 | Buy |
| 50-day SMA: | 104.45 | Buy |
| 200-day SMA: | 88.21 | Buy |
| 8-day EMA: | 109.65 | Buy |
| 20-day EMA: | 107.7 | Buy |
| 50-day EMA: | 104.48 | Buy |
| 200-day EMA: | 91.25 | Buy |
Black Diamond Therapeutics Earnings Growth & BDTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $0.08 per share.
Ligand Pharmaceuticals Earnings Growth & LGND Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and an increase next year of $0.84 per share.
Black Diamond Therapeutics Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ligand Pharmaceuticals Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||